SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001213900-18-015502
Filing Date
2018-11-13
Accepted
2018-11-13 16:23:44
Documents
41
Period of Report
2018-09-30

Document Format Files

Seq Description Document Type Size
1 QUARTERLY REPORT f10q0918_bisoncapitalacq.htm 10-Q 209009
2 CERTIFICATION f10q0918ex31-1_bisoncapital.htm EX-31.1 8133
3 CERTIFICATION f10q0918ex31-2_bisoncapital.htm EX-31.2 8075
4 CERTIFICATION f10q0918ex32-1_bisoncapital.htm EX-32.1 3839
5 CERTIFICATION f10q0918ex32-2_bisoncapital.htm EX-32.2 3699
  Complete submission text file 0001213900-18-015502.txt   1212260

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE FILE bcacu-20180930.xml EX-101.INS 138684
7 XBRL SCHEMA FILE bcacu-20180930.xsd EX-101.SCH 20086
8 XBRL CALCULATION FILE bcacu-20180930_cal.xml EX-101.CAL 28473
9 XBRL DEFINITION FILE bcacu-20180930_def.xml EX-101.DEF 35620
10 XBRL LABEL FILE bcacu-20180930_lab.xml EX-101.LAB 121659
11 XBRL PRESENTATION FILE bcacu-20180930_pre.xml EX-101.PRE 90902
Mailing Address 609-610 21ST CENTURY TOWER 40 LIANGMAQIAO ROAD, CHAOYANG DISTRICT BEIJING F4 100016
Business Address 609-610 21ST CENTURY TOWER 40 LIANGMAQIAO ROAD, CHAOYANG DISTRICT BEIJING F4 100016 9493506999
Bison Capital Acquisition Corp. (Filer) CIK: 0001697805 (see all company filings)

IRS No.: 000000000 | State of Incorp.: D8 | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-38120 | Film No.: 181178306
SIC: 2834 Pharmaceutical Preparations
Assistant Director 1